Anupam Rasayan India delivered exceptional financial performance in the December 2025 quarter, with consolidated net profit rising 12% to ₹61 crore compared to ₹54.21 crore in the corresponding quarter of the previous year. According to reports from The Economic Times, this represents a significant improvement in the company's bottom-line performance during the quarter ended December 2025, demonstrating continued growth momentum as stated by Managing Director Anand Desai.
The company's sales revenue increased 31.35% to ₹512.44 crore in Q3 FY2026, up from ₹390.14 crore in the same period last year. As reported by The Economic Times, this substantial revenue growth demonstrates the company's strong operational performance and market expansion during the quarter. The company's expenses remained higher at ₹454.59 crore against ₹327 crore in the said period, reflecting increased business activities and operational scale.
Operating profit margin (OPM) stood at 24.88% in the December 2025 quarter, compared to 31.86% in the corresponding quarter of the previous year. According to the financial data reported by The Economic Times, the company's profit before depreciation and tax (PBDT) increased 6% to ₹94.42 crore from ₹88.79 crore year-on-year, while profit before tax (PBT) grew 1% to ₹59.95 crore from ₹59.50 crore.
A significant strategic development during the period has been the signing of a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States, as reported by The Economic Times. This acquisition strengthens the company's global footprint, enhances capabilities in advanced custom synthesis, and deepens access to regulated markets and innovator customers in North America. The acquisition is expected to significantly expand the company's global presence and custom synthesis capabilities in the North American market.
